Position in VTRS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$470,826
+$145,114 QoQ
Shares Held
29,649
+23.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#421
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OPPENHEIMER & CO INC holds $19,819,101 across 9 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
116,275 | $8,355,521 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
47,800 | $8,056,212 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
3,090 | $1,674,254 | |
| 4 | VTRS |
Viatris Inc
This page
|
29,649 | $470,826 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,574 | $324,367 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
2,757 | $305,861 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
8,973 | $220,825 | |
| 8 | AQST |
Aquestive Therapeutics, Inc.
|
51,052 | $212,376 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $470,826 | 29,649 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $325,712 | 24,109 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $283,262 | 22,752 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $236,481 | 23,887 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $237,100 | 26,551 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $299,702 | 34,409 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $311,934 | 25,055 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $290,888 | 25,055 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $304,783 | 28,672 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $411,213 | 34,440 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $345,975 | 31,946 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $346,007 | 35,092 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $355,208 | 35,592 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $558,739 | 58,081 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $653,164 | 58,685 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $609,341 | 71,519 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,348,399 | 128,787 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,539,987 | 141,543 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,163,068 | 159,872 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,979,248 | 146,070 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,134,926 | 149,400 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,956,680 | 140,063 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $1,653,017 | 88,208 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||